Executive Summary & Why This Matters in R&D Pipelines
Whether you are running phenotypic screens, fragment campaigns, or structure‑based exploration, chemical compounds are the fuel of discovery. Poorly characterized materials inflate false positives/negatives, derail downstream SAR, and cost months. ChemDiv aligns sourcing, QC, and documentation so your assays see the intended structure at the intended purity and concentration. Our catalog provides rapid access to in‑stock chemical compounds, while our services extend to custom synthesis, pre‑plated delivery, and scale‑up.
How to Evaluate chemical compounds (chemical compounds Selection Framework)
A practical selection framework for chemical compounds balances three dimensions: (1) chemical space coverage (diversity, scaffolds), (2) fitness for biology (property filters, liabilities), and (3) operational reliability (QC/QA, documentation, supply chain). Below we expand key gates teams should formalize in SOPs.
Quality Systems (QC/QA, CoAs, analytical methods)
For screening‑grade chemical compounds, ensure identity and purity are evidenced—LC‑MS mass match, HPLC or UPLC purity, and 1H NMR for structural confirmation. For confirmation/secondary assays, consider higher thresholds (e.g., ≥95%) and orthogonal verification or qNMR when appropriate. Reference method validation principles (specificity, accuracy, precision, LOD/LOQ, robustness) per ICH Q2(R2). Request structured QC data and CoAs that can be ingested by LIMS/ELN.
Supply Chain Reliability & Lead Times
Delivery speed and predictability matter. ChemDiv lists stock availability and offers multiple delivery formats (dry powder vials, 96/384‑well DMSO solutions) with typical lead times as short as 1–2 business days for small orders and ~1 week worldwide for common pre‑plated sets—ideal for fast iteration on chemical compounds in screens.
Compliance & Documentation (REACH/SDS/GxP where applicable)
Match your use case. Screening‑grade chemical compounds are typically supplied for research use only (RUO), accompanied by Safety Data Sheets (SDS) compliant with the UN GHS format and, where relevant, REACH considerations for import/use in the EU. If you’re bridging toward GMP, align with ICH Q7 expectations for API manufacturing and keep analytical procedures conformant with ICH Q2(R2). Residual solvent policies should follow ICH Q3C(R8) limits; maintain traceable certificates for any solvent‑switch or drying steps.
IP, Confidentiality, and Data Integrity
For custom or proprietary chemical compounds, implement a CDA and a sample‑level anonymization scheme that preserves structure‑activity learning while protecting scaffold IP. Tie each vial, plate, or well to immutable metadata (lot, QC files, storage, formulation) and store CoAs in your ELN with hash-based checksums to ensure data integrity.
Where ChemDiv Fits (Products, Libraries, Custom Services)
ChemDiv delivers breadth and depth—diverse chemical compounds for screening, targeted sets by modality or biology, and custom synthesis that closes gaps in SAR space. All offerings integrate practical QC and documentation.
Screening Libraries & Medicinal Chemistry Support
- 2M in‑stock screening chemical compounds searchable by exact, substructure, or similarity.
- Pre‑plated sets (e.g., 100k diverse) delivered at 10 mM, frozen, 96/384 formats; fresh prep from dry powders improves stability.
- Focused & targeted libraries (e.g., fragments including 19F/X‑ray sets; covalent fragments) spanning specific mechanisms and target classes.
- QC policy: LC‑MS and/or 1H NMR; typical ≥90% purity for primary screens, with higher thresholds on request.
Custom Synthesis & Scale‑Up Options
When your hypothesis demands bespoke chemical compounds, our synthetic chemists provide route scouting, parallel synthesis, purification, and scale‑up with analytical validation (HPLC, LC‑MS, NMR; preparative LC as needed). We can supply dry powders, DMSO solutions, and plate maps aligned to assay layouts for rapid execution.
Case Snapshots / Achievements (verifiable highlights)
- Scale and access: online catalog with 2M screening chemical compounds and >75k building blocks in stock.
- Delivery formats: dry powder vials, 96/384‑well DMSO at 10 mM, and plate‑cherry‑picks (pre‑plated libraries).
- Lead times: small orders often ship in 1–2 days; broader selections in 2–4 weeks; pre‑plated sets typically ~1 week.
- External collaboration: partnership announced to support Tri‑Institutional Therapeutics Discovery Institute programs (Memorial Sloan Kettering, Rockefeller University, Weill Cornell), demonstrating scalable discovery support.
Technical Deep Dive (Methods, Workflows, Example Schematics)
This section summarizes pragmatic steps to keep chemical compounds reliable from receiving to assay.
Sample SOP Excerpts (non‑proprietary)
- Receiving: Verify lot, structure ID, and format against PO. Record storage temperatures and tamper seal state. Capture vendor QC PDFs for the ELN.
- Primary intake QC: Spot LC‑MS to confirm mass; quick HPLC purity check; if borderline, escalate to orthogonal 1H NMR or qNMR. Apply acceptance rules (e.g., ≥90% purity for primary screens).
- Solution prep: Prepare fresh DMSO from dry powder when feasible. Log exact mass and final concentration; verify by UV where appropriate.
- Plate mapping: Use barcoded plates; include controls and intra‑plate positional randomization. Export plate maps to assay systems.
- Assay QA: Track Z′‑factor or equivalent QC metrics. Reject runs with drift or edge effects beyond pre‑set thresholds. Re‑plate chemical compounds as needed.
- Stability & storage: Follow RUO storage guidance; track freeze–thaw counts; recheck purity after extended storage.
Analytical Readouts & Acceptance Criteria
- LC‑MS: Monoisotopic mass match within instrument tolerance; absence of significant adducts or degradants.
- HPLC/UPLC: Chromatographic purity by area; for borderline chemical compounds or when UV is not specific, favor orthogonal readouts.
- 1H NMR/qNMR: Structural confirmation; qNMR for absolute purity where needed.
- Residual solvents: Document per ICH Q3C(R8); apply appropriate methods (e.g., headspace GC) if critical to application.
- Data integrity: Link each vial/well to raw instrument files and analysis reports in your ELN with audit trails.
Buyer’s Toolkit (Checklists, RFP prompts, comparison table)
Checklist for Selecting chemical compounds Vendors
- QC package (LC‑MS, HPLC/UPLC chromatogram, 1H NMR; optional qNMR).
- Purity thresholds appropriate to stage (≥90% screen; ≥95% confirmatory/medchem).
- SDS in GHS format; REACH statements where applicable.
- Plate maps, concentration certificates, and storage guidance for chemical compounds.
- Lead‑time commitments; service levels for re‑supply and cherry‑pick.
- Data integrity (lot traceability, file hashes) and IP/confidentiality terms.
RFP Prompts You Can Reuse
- “Provide LC‑MS and HPLC purity for each lot; define purity integration method.”
- “Confirm 1H NMR (solvent, field strength) and supply raw data where available.”
- “Specify residual solvent handling vs. ICH Q3C(R8).”
- “Deliver chemical compounds as dry powder and/or fresh 10 mM DMSO; indicate freeze–thaw limits.”
- “Include plate maps (CSV/SDF) and well‑level barcodes for automation.”
- “State typical lead time (small & large orders), courier options, and customs documentation.”
Comparison Table: Common Supply Options
Option | Best for | Pros | Considerations |
---|---|---|---|
Dry powder vials | Long‑term storage; sensitive chemical compounds | Max stability; flexible concentrations | Requires in‑house weighing and solution QC |
Fresh DMSO solutions | HTS deployment; rapid repeats | Time‑saving; plate‑ready | Track freeze–thaw; periodic re‑QC |
Pre‑plated libraries | Large, standardized screens | Uniform layout; fast delivery | Fixed plate content; plan cherry‑picks |
FAQs (procurement, QA, logistics, documentation)
How fast can I get plate‑ready chemical compounds?
Small selections can ship in ~1–2 business days. Pre‑plated or larger sets typically arrive within about a week, with broader picks delivered in 2–4 weeks depending on scope and documentation needs.
What analytical files do I receive?
CoAs include LC‑MS and/or HPLC plus 1H NMR where appropriate. For critical series, we can add qNMR or provide raw data files upon request.
Can you exclude PAINS or flagged substructures?
Yes—ChemDiv can filter libraries to remove common assay interferents and known frequent hitters before shipment, and will document filtering rules for your records.
What about REACH and SDS?
Shipments include SDS in GHS format. For EU deliveries of chemical compounds, we support REACH considerations as appropriate for the intended research use.
Do you offer confidentiality for custom work?
We execute bilateral CDAs and align on anonymized identifiers for proprietary chemical compounds; project data remains your property.
About ChemDiv (E‑E‑A‑T signals, team, facilities)
ChemDiv is a discovery chemistry partner to pharma, biotech, and CRO organizations worldwide. Over multiple decades, we’ve delivered libraries and services across oncology, CNS, immunology, infection, and cardiometabolic programs—supporting real‑world decisions with qualified chemical compounds, reliable QC, and practical documentation.
- Company profile and track record across therapeutic areas.
- QC standards (LC‑MS/1H NMR; typical purity ≥90% for screening).
- Catalog access (2M screening chemical compounds; >75k building blocks).
- Analytical capabilities (HPLC, LC‑MS, NMR; preparative options).
- Contact & logistics (San Diego HQ; global shipping windows).
- Privacy & policies.
References & Further Reading (authoritative)
- Lipinski CA et al. “Experimental and computational approaches to estimate solubility and permeability…” Adv Drug Deliv Rev (2001). PubMed
- Veber DF et al. “Molecular properties that influence the oral bioavailability of drug candidates.” J Med Chem (2002). PubMed
- Baell JB, Holloway GA. “New substructure filters for removal of PAINS…” J Med Chem (2010). PubMed
- Bemis GW, Murcko MA. “The properties of known drugs. 1. Molecular frameworks.” J Med Chem (1996). PubMed
- ICH Q2(R2) “Validation of Analytical Procedures.” (2023/2024). ICH PDF
- ICH Q7 “Good Manufacturing Practice for APIs.” (Current). ICH PDF
- ICH M7(R2) “Assessment and control of DNA‑reactive (mutagenic) impurities.” (2023). ICH PDF
- ICH Q3C(R8) “Impurities: Guideline for Residual Solvents.” (2021). ICH PDF
- UN GHS (“Purple Book”) & SDS guidance. UNECE
- REACH Regulation (EC) No 1907/2006. EUR‑Lex
- PubChem (NIH) — open chemistry database. About PubChem
- Zhang JH et al. “A Simple Statistical Parameter for Use in Evaluation and Validation of HTS Assays.” J Biomol Screen (1999). PubMed
- Brideau C et al. “Improved statistical methods for hit selection in HTS.” J Biomol Screen (2003). PubMed
- Assay Guidance Manual — HTS assay validation. NCBI
ChemDiv pages cited
- Catalog (2M screening compounds; >75k building blocks): chemdiv.com/catalog/
- Screening compounds (search & purchase): chemdiv.com/catalog/screening-compounds/
- Screening libraries (QC overview & purity policy): chemdiv.com/catalog/screening-libraries/
- Focused & targeted libraries (e.g., fragments): chemdiv.com/catalog/focused-and-targeted-libraries/
- Pre‑plated libraries (formats and delivery): chemdiv.com/catalog/preplated-libraries/
- Scale‑up & analytics (HPLC, LC‑MS, NMR): chemdiv.com/.../scale-up-synthesis/
- Delivery/lead‑time examples on product pages: chemdiv.com/.../0109-0054 and chemdiv.com/.../D203-0007
- Contact & address: chemdiv.com/company/contacts/
- Company overview: chemdiv.com/company/
Call to Action (Request a Quote • Talk to a Scientist • Explore Catalog)
Ready to accelerate your next screen or SAR cycle with fit‑for‑purpose chemical compounds? We’ll help you select, qualify, and deliver what your biology needs—fast.
For research use only. Not for diagnostic or therapeutic use. Documentation packages are aligned to RUO needs; contact us to discuss enhanced packages for advanced development work.